| Ginger Leigh Owens, | |
|
1403 Morning Sun Dr, Ballwin, MO 63021-8414 | |
| (314) 644-8655 | |
| Not Available |
| Full Name | Ginger Leigh Owens |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 1403 Morning Sun Dr, Ballwin, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780368241 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 2017021564 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ginger Leigh Owens, 1403 Morning Sun Dr, Ballwin, MO 63021-8414 Ph: (314) 644-8655 | Ginger Leigh Owens, 1403 Morning Sun Dr, Ballwin, MO 63021-8414 Ph: (314) 644-8655 |
News Archive
Curis, Inc., a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today reported its financial results for the third quarter ended September 30, 2009.
April is National Cancer Control Month, which focuses on the prevention, detection, and treatment of cancer and on efforts to improve the quality of life of the more than 11 million cancer survivors in the United States.
Since the WHO developed Directly Observed Therapy, Short-course (DOTS) in 1994 for the treatment of tuberculosis, approximately 36 million people have successfully completed treatment and been cured over the past 15 years, according to new data released by the WHO on Tuesday, health-e reports (Thom, 12/8).
Affecting an estimated one in eight people older than 75, aortic valve stenosis - a narrowing of the heart's main artery - makes the heart work harder to supply the body with blood, potentially limiting patient's activity levels an quality of life. Ultimately, aortic stenosis can lead to stroke, arrhythmia, heart failure and death.
Cell Therapeutics, today announced that the Office of New Drugs of the U.S. Food and Drug Administration after carefully reviewing the materials CTI submitted in support of its appeal, the reviews of the New Drug Application for pixantrone prepared by the FDA staff, the transcript of the March 22, 2010 Oncology Drugs Advisory Committee meeting and consulting with the Center for Drug Evaluation and Research's Deputy Director of Clinical Science and the Office of Biostatistics, concluded that accelerated approval of pixantrone NDA 022481 may not necessarily be out of reach based on a single controlled clinical trial, provided two key matters can be satisfactorily resolved.
› Verified 5 days ago
Deborah Lynn Liefer, RNFA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 705 Clayworth Dr, Ballwin, MO 63011 Phone: 636-734-0386 | |
Mrs. Victoria I Hodge, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 50 Meramec Trail Dr, Ballwin, MO 63021 Phone: 314-880-9774 | |
Amie Melissa Clark, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 13515 Barrett Parkway Dr, Suite 170, Ballwin, MO 63021 Phone: 314-775-2811 | |
Kay Summers, R.N Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 219 Dale Ct, Ballwin, MO 63011 Phone: 314-805-1148 | |
Jennifer Williams, FNP-C Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 452 Sovereign Ct Ste A, Ballwin, MO 63011 Phone: 636-222-8699 Fax: 636-238-5434 | |
Diana Sundara, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 615 Amberwood Ln, Ballwin, MO 63021 Phone: 314-517-5048 | |
Mrs. Colleen E Steiner, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 50 Meramec Trail Dr, Ballwin, MO 63021 Phone: 636-923-2387 Fax: 636-923-2388 |